These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33531872)

  • 1. P21 is not a prognostic marker for rectal cancer - five-year follow up study of rectal cancer in stages I-IV.
    Kozłowska-Geller MA; Głuszek SZ; Lewitowicz P
    Contemp Oncol (Pozn); 2020; 24(4):247-251. PubMed ID: 33531872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow-up study of stage I-IV rectal cancer including EGFR immunoexpression and p21 immunoactivity.
    Kozłowska-Geller M; Głuszek S; Lewitowicz P
    Prz Gastroenterol; 2021; 16(4):330-338. PubMed ID: 34976241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy.
    Sogawa N; Takiguchi N; Koda K; Oda K; Satomi D; Kato K; Ishikura H; Miyazaki M
    Int J Oncol; 2002 Oct; 21(4):787-93. PubMed ID: 12239617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?
    Schwandner O; Bruch HP; Broll R
    Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of p21 and p27 protein, apoptosis, clinical and histologic factors in rectal cancer without lymph node metastases.
    Schwandner O; Bruch HP; Broll R
    Eur Surg Res; 2002; 34(6):389-96. PubMed ID: 12403937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of p53, p21, and p27 expressions in rectal carcinoma.
    Lebe B; Sarioğlu S; Sökmen S; Ellidokuz H; Füzün M; Küpelioğlu A
    Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):38-44. PubMed ID: 15722792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
    Rau B; Sturm I; Lage H; Berger S; Schneider U; Hauptmann S; Wust P; Riess H; Schlag PM; Dörken B; Daniel PT
    J Clin Oncol; 2003 Sep; 21(18):3391-401. PubMed ID: 12885834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A five-year follow up study of stage I-IV of rectal cancer with an emphasis on epidermal growth factor over-expression.
    Kozłowska-Geller MA; Lewitowicz P; Głuszek SZ
    Pol J Pathol; 2021; 72(2):124-129. PubMed ID: 34706519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic role of apoptosis mediators in rectal adenocarcinoma.
    Seicean R; Crisan D; Boers JE; Mocan T; Seicean A; Funariu G; Ciuce C
    Hepatogastroenterology; 2011; 58(110-111):1490-4. PubMed ID: 21940317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
    Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
    J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
    Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
    Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue.
    Stift A; Prager G; Selzer E; Widder J; Kandioler D; Friedl J; Teleky B; Herbst F; Wrba F; Bergmann M
    Int J Oncol; 2003 Nov; 23(5):1269-75. PubMed ID: 14532965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer.
    Stein JP; Ginsberg DA; Grossfeld GD; Chatterjee SJ; Esrig D; Dickinson MG; Groshen S; Taylor CR; Jones PA; Skinner DG; Cote RJ
    J Natl Cancer Inst; 1998 Jul; 90(14):1072-9. PubMed ID: 9672255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21 and p53 Immunostaining and survival following systemic chemotherapy for urothelial cancer.
    Jankevicius F; Goebell P; Kushima M; Schulz WA; Ackermann R; Schmitz-Dräger BJ
    Urol Int; 2002; 69(3):174-80. PubMed ID: 12372883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
    Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
    Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
    Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
    J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
    Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
    Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas.
    Marijnen CA; Kapiteijn E; Nagtegaal ID; Mulder-Stapel AA; van de Velde CJ; Schrier PI; Peltenburg LT; van Krieken JH
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):720-8. PubMed ID: 11849795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of p21(WAF-I) protein expression with prognosis in advanced prostate cancer treated by androgen ablation.
    Omar EA; Behlouli H; Chevalier S; Aprikian AG
    Prostate; 2001 Nov; 49(3):191-9. PubMed ID: 11746264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
    Baretton GB; Klenk U; Diebold J; Schmeller N; Löhrs U
    Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.